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Obesity is a major public health problem in developed countries resulting from 
increased food intake and decreased energy consumption and usually associated with 
abnormal lipid metabolism. Here we show that DEC1, a basic helix-loop-helix 
transcription factor, plays an important role in the regulation of lipid consumption in 
mouse brown adipose tissue (BAT), which is the major site of thermogenesis. 
Homozygous Dec1 deletion attenuated high-fat-diet-induced obesity, adipocyte 
hypertrophy, fat volume, and hepatic steatosis. Furthermore, DEC1 deficiency 
increased body temperature during daytime and enhanced the expression of uncoupler 
protein 1, a key factor of thermogenesis, and various lipolysis-related genes in 
interscapular BAT. In vitro experiments suggested that DEC1 suppresses the expression 
of various lipolysis-related genes induced by the heterodimer of peroxisome 
proliferator-activated receptor g and retinoid X receptor a (RXRa) through direct 
binding to RXRa. These observations suggest that enhanced lipolysis in BAT caused by 
DEC1 deficiency leads to an increase in lipid consumption, thereby decreasing lipid 
accumulation in adipose tissues and the liver. Thus, DEC1 may serve as an energy-




Obesity is a major risk factor for many chronic diseases, including cardiovascular disease, 
lipid disorders, atherosclerosis, hypertension, and diabetes (Klein et al. 2004). The cause of 
obesity is the disruption of the balance between intake and consumption of lipids and 
carbohydrates. Modulation of lipid metabolism, which is under the control of peroxisome 
proliferator-activated receptor (PPAR) (Lefterova et al. 2008; Nielsen et al. 2008), is 
considered a promising therapeutic target for preventing obesity and/or its related diseases. In 
addition, the regulation of lipid metabolism is closely related to energy homeostasis in the 
body. 
 Energy homeostasis, including nutrient metabolism and thermogenesis, is subject to 
circadian regulation (Cagampang & Bruce 2012; Mohawk et al. 2012; Shostak et al. 2013). 
The molecular clock system regulates the circadian rhythms of the sleep-wake and feeding 
cycles, affecting energy homeostasis in various tissues including adipose tissues (Mohawk et 
al. 2012; Shostak et al. 2013). Several studies have shown that clock components, such as 
CLOCK and BMAL1, are involved in the regulation of adipogenesis and lipogenesis, and 
these factors are consequently also related to obesity (Turek et al. 2005; Zanquetta et al. 
2010; Paschos et al. 2012). In addition, another clock regulator PER2 controls lipid 
metabolism by interacting with PPARg (Grimaldi et al. 2010). These facts suggest that the 
clock system plays a role in the development of obesity through the disruption of lipid 
homeostasis. 
 The basic helix-loop-helix transcription factor, DEC1 (also known as BHLHE40, Stra13, 
or Sharp2), and the structurally related protein, DEC2 (also known as BHLHE41 or Sharp1), 
are ubiquitously expressed and implicated in neurogenesis (Rossner et al. 1997), cell growth 
arrest (Sun & Taneja 2000), chondrogenesis (Shen et al. 2002), and carcinogenesis (Miyazaki 
et al. 2002). DEC1 and DEC2, the expression of which is regulated by the CLOCK:BMAL1 
heterodimer through the CACGTG E-box, are also involved in a core feedback loop of the 
molecular clock system (Honma et al. 2002; Nakashima et al. 2008; Kato et al. 2014). In 
addition, our previous study showed that forced expression of DEC1 suppressed the 
adipogenic differentiation of human mesenchymal stem cells (Iwata et al. 2006). Other 
studies have also reported the involvement of DEC1 in adipogenesis (Yun et al. 2002; Park & 
Park 2012). These findings suggest that DEC1 plays an important role in the control of 
adipogenesis and lipid metabolism. 
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 In this study, we show that DEC1 deficiency prevents obesity in mice fed a high-fat diet. 
We also demonstrate that DEC1 suppresses the expression of lipolysis-related genes in brown 
adipose tissue (BAT) through binding to the PPARg: retinoid X receptor α (RXRα) 
heterodimer, which is a key regulator of adipogenesis and lipid metabolism (Lefterova et al. 
2008; Nielsen et al. 2008; Wakabayashi et al. 2009). 
 
2 RESULTS 
2.1 DEC1 deficiency attenuates high-fat-diet-induced obesity.  
In our previous study, we established Dec1/ mice (Nakashima et al. 2008), and confirmed 
Dec1 deficiency in the adipose tissues and liver used in this study (see Figure 3b). Although 
DEC1 has been suggested to be involved in adipogenic differentiation (Yun et al. 2002; Iwata 
et al. 2006; Park & Park 2012), the body weight of Dec1/ mice is almost the same as that of 
wild-type (WT) mice (Figure 1a). We therefore assessed whether DEC1 deficiency affects 
obesity or other disorders related to lipid metabolism when mice are fed a high-fat diet. When 
fed such a diet from 4 weeks of age, Dec1/ mice gained less weight than WT mice, and the 
difference became more pronounced with age (Figure 1a) even though food intake per body 
weight by these mice was similar throughout the experimental period (data not shown). 
 To assess the increase in the volumes of subcutaneous and visceral fat, we investigated 
the distribution of fat depots in the abdomen of 14-week-old mice (10 weeks into the feeding 
diet) using micro-computed tomography (micro-CT). The abdominal mid-section between 
the L1–L6 lumbar vertebrae, which correlates with total adiposity and explanted fat pad 
weight (Lubura et al. 2012), was selected for this analysis; the total and fat volumes of this 
region were significantly smaller in Dec1/ mice than in WT on both control and high-fat 
diets (Figure 1b,c). Taken together, these data suggest that DEC1 deficiency suppresses the 
body weight gain, probably due to the decrease in lipid accumulation, although body weight 
gain was not significantly different between WT and Dec1/ mice on the control diet.  
 
2.2 DEC1 deficiency reduces lipid accumulation in white adipose tissue (WAT), BAT, 
and liver.  
Histological examination showed that adipocytes in WAT became hypertrophic in both WT 
and Dec1/ mice fed a high-fat diet (Figure 1d). However, adipocytes in Dec1/ mice were 
apparently smaller than those in WT. Average sizes of adipocytes in WAT were 68.5 ± 0.6 
and 49.9 ± 0.5 µm in WT and Dec1/ mice fed a control diet, respectively; and 103.0 ± 1.1 
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and 86.9 ± 0.9 in WT and Dec1/ mice fed a high-fat diet, respectively (Figure 1e). Thus, 
DEC1 deficiency significantly reduced adipocyte size in mice fed both control and high-fat 
diets compared with the WT mice under the same dietary regimens. 
 Decreased lipid accumulation was observed in the BAT of Dec1/ mice in both control 
and high-fat diet groups compared with WT mice (Figure 1f,g). The lipid-accumulated area 
in the liver was also smaller in Dec1/ mice fed a high-fat diet than that in WT mice (Figure 
1h,i). In addition, when fed a high-fat diet, WT mice appeared to develop severe hepatic 
steatosis compared with Dec1  /   mice (Figure 1j). These findings suggest that DEC1 
deficiency prevents obesity through decreased lipid accumulation in adipose tissues and the 
liver.  
 
2.3 DEC1 deficiency increases body temperature and Ucp1 expression in BAT.  
It is likely that increased energy consumption in the body attenuates obesity or hepatic 
steatosis in Dec1/ mice. Since DEC1 is a member of the molecular clock system (Honma et 
al. 2002; Kato et al. 2014), it is necessary to examine the effect of DEC1 deficiency at least 
twice a day. Consequently, we measured the core temperature of mice at Zeitgeber time (ZT) 
2 and ZT14, corresponding to the times of trough and peak core temperatures, respectively, in 
normal mice (Hannibal et al. 2011). The core temperature at ZT14 was almost equal in the 
four groups of mice, irrespective of diet or genotype. However, the core temperature of Dec1
/ mice at ZT2, which is the resting phase during the daytime, was significantly higher than 
that of WT mice on both diets (Figure 2a).  
 In Dec1/ mice fed a high-fat diet, the core temperature at ZT2 and ZT14 was almost the 
same (Figure 2a). The increase in the core temperature of Dec1/ mice over WT at ZT2 
suggested that energy consumption and thermogenesis, which are crucial for body 
temperature control, were enhanced. Therefore, we examined the expression of uncoupling 
protein 1 (Ucp1), which is preferentially expressed in BAT and is responsible for 
thermogenesis (Richard & Picard 2011). Ucp1 expression increased in the BAT of WT and 
Dec1
/ mice fed a high-fat diet; Ucp1 levels were higher in Dec1/ mice than in WT under 
the same dietary condition (Figure 2b). The increase in Ucp1 expression in the BAT of Dec1/
 mice fed a high-fat diet was more prominent at ZT2, which is the time point at which the 
core temperature was elevated.  
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2.4 DEC1 deficiency increases gene expression related to lipid metabolism in BAT.  
Since UCP1-dependent thermogenesis requires the supply of lipids as substrates (Cannon & 
Nedergaard 2004), we examined the expression of the following lipolysis-related genes: 
lipoprotein lipase (Lpl), a gene involved in the uptake of fatty acid from the plasma into cells 
(Schoonjans et al. 1996); carnitine palmitoyltransferase 1b (Cpt1b), an essential gene for the 
uptake of fatty acids into mitochondria for b-oxidation (Zhang et al. 2016); cytochrome c 
oxidase subunit IV (Cox4) and ATP synthase F1 complex b subunit (Atp5b), genes coding for 
mitochondrial electron transport proteins (Sun et al. 2015); several isoforms of acyl-CoA 
dehydrogenase (Acad1, Acad4, and Acad6), genes of key enzymes in fatty acid b-oxidation 
(Gulick et al. 1994); and Pparg, a key transcription factor gene involved in lipid metabolism. 
In both genotypes, the high-fat diet enhanced the expression of most of these genes in BAT 
(Figure 3a). DEC1 deficiency also increased their mRNA levels at ZT2 or ZT14, or both. In 
contrast, transcript levels of these genes in WAT and liver were very low and did not 
significantly differ between the two genotypes, irrespective of the diet, although Lpl and 
Pparg were also expressed at high levels in WAT.  
 Thus, DEC1 deficiency significantly increased the expression of Ucp1 as well as genes 
involved in fatty acid b-oxidation and mitochondrial energy metabolism in BAT, likely 
causing the higher body temperature (Figure 2b) and decreased fat depots (Figure 1b,c) 
observed in these animals. DEC2 (a DEC1 isoform) could not compensate for DEC1-deletion 
in BAT because Dec2 expression was not upregulated in the BAT of Dec1/ mice (Figure 3b).  
 
2.5 DEC1 directly suppresses the activity of the PPARg:RXRa heterodimer.  
Next, the underlying mechanism by which DEC1 affects gene expression was investigated. 
Ucp1, Acad1, Acad4, and Acad6, along with Cpt1b, Cox4 Atp5b, and Lpl, which showed 
altered expression in the BAT of Dec1/ mice (see above), are targets of PPARg (Lefterova et 
al. 2008; Nielsen et al. 2008; Wakabayashi et al. 2009). Because PPARg induces 
transcription of these genes by binding to PPAR responsive elements (PPREs) as a 
heterodimer with RXRa, we examined whether DEC1 modulates the transcriptional activity 
of the consensus PPRE (Lemay & Hwang 2006) in the presence of the PPARg:RXRa 
heterodimer using luciferase reporter assays. The luciferase activity of the consensus PPRE 
reporter was enhanced by the PPARg:RXRa heterodimer in 3T3-L1 differentiated 
adipocytes; the transactivation by the PPARg:RXRa heterodimer was significantly 
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suppressed by DEC1, although the activity of the reporter was not affected by DEC1 alone 
(Figure 4a).  
 To examine the interaction of DEC1 with PPARg target genes in cells, we performed 
chromatin immunoprecipitation (ChIP) assays using 3T3-L1 cells; anti-DEC1 antibodies; and 
primer sets for the Lpl, perilipin 1 (Plin1: lipid droplet associated protein), and Pparg genes 
(Schoonjans et al. 1996; Nagai et al. 2004). Using the anti-DEC1 immunoprecipitates or the 
input samples from 3T3-L1 adipocytes as a template, PCR products with the expected sizes 
for the respective PPRE regions were generated (Figure 4b). These findings demonstrate that 
DEC1 binds to the PPRE region of PPARg target genes in cells, probably through binding to 
the PPARg:RXRa heterodimer. 
 Cho et al. (2009) have already demonstrated that DEC1 suppresses transcriptional 
activation by nuclear receptors such as liver X receptor α, farnesoid X receptor, vitamin D 
receptor, and retinoic acid receptor α through direct binding to their heterodimerization 
partner, RXRα. We therefore examined whether DEC1 binds to PPARg or RXRa to inhibit 
the activity of the PPARg:RXRa heterodimer. We transfected expression plasmids for 
FLAG-DEC1, RXRa, and PPARg into human embryonic kidney (HEK) 293 cells and 
examined their interaction by immunoprecipitation using anti-FLAG antibodies. RXRa 
coprecipitated with FLAG-DEC1, whereas PPARg was detected only in the presence of both 
FLAG-DEC1 and RXRa (Figure 4c), indicating that DEC1 directly associates with RXRa, 
but not with PPARg.  These results, together with those of the luciferase reporter (Figure 4a) 
and ChIP (Figure 4b) assays, demonstrate that DEC1 interacts with RXRa at the PPREs in 




Here, we examined the effects of DEC1 deficiency on obesity-related phenotypes such as 
body weight gain, lipid accumulation, and thermogenesis in mice. The body weight of Dec1/
 mice fed a high-fat diet was lower than that of WT mice maintained under the same 
conditions; fat volume in the abdomen of Dec1/ mice was significantly smaller than that of 
WT. In addition, body temperature increased in Dec1 / mice compared with WT mice. 
Correspondingly, the expression of various lipid-metabolizing genes in Dec1/ mice was 
upregulated in BAT, the major site of thermogenesis, but not in WAT and the liver. DEC1 
 8 
suppressed the transcriptional activity of the PPARg:RXRa-heterodimer, a key transcription 
factor in lipid metabolism, by directly binding to RXRa. These results suggest that DEC1 is a 
potent regulator of lipid and energy metabolism, and that suppressive regulation by DEC1 via 
binding to the PPARg:RXRa heterodimer is an effective way to save lipid energy.  
 Genome-wide analyses identified more than 5,000 binding sites of the PPARg:RXRa 
heterodimer in adipocytes (Lefterova et al. 2008; Nielsen et al. 2008; Wakabayashi et al. 
2009). Most lipid-metabolizing genes influenced by DEC1 deficiency are included in the lists 
of PPARg target genes in those reports. Figure 5 illustrates the possible effects of DEC1 
deficiency in reducing the development of obesity by the transcriptional regulation of PPARg 
target genes via PPREs involved in lipid consumption in BAT, the lipid flow from WAT to 
BAT, and the accumulation of lipid in WAT. DEC1 deletion results in the upregulation of 
Ucp1 and many lipolysis-related genes responsible for b-oxidation (Acad), lipid transport 
(Lpl and Cpt1b) and electron transport (Cox4 and Atp5b) in BAT, leading to increased lipid 
consumption and thermogenesis, which require the enhancement of lipid supply from WAT 
to BAT. A recent study has demonstrated that BAT is a master regulator of triglyceride 
clearance: it efficiently consumes fatty acids according to a metabolic program (Bartelt et al. 
2011). Accelerated lipid intake and consumption in the BAT of Dec1/ mice may result in a 
decrease in lipid accumulation and adipocyte size in WAT, leading to the prevention of 
obesity. In addition, the increased consumption of lipids in DEC1-deficient BAT appears to 
reduce the development of hepatic steatosis, the ectopic accumulation of lipids in the liver. 
 Similar to this study, Cho et al. (2009) demonstrated that DEC1 could bind to RXRa via 
an LxxLL motif in DEC1, a motif typically found in cofactors of nuclear receptors 
(Rosenfeld et al. 2006), to repress the transactivation activity of nuclear receptors that 
function with RXRa as a partner, such as the liver X receptor a, farnesoid X receptor, 
vitamin D receptor, and retinoic acid receptor a, although in vivo effects were not 
demonstrated. The results in this study demonstrate that DEC1 represses the transactivation 
activity of another partner of RXRa, i.e., PPARg, and thereby regulates lipid metabolism in 
BAT. To our knowledge, this is the first report to illustrate the in vivo action of DEC1 
through binding to RXRa. 
 Most lipid-metabolizing genes examined in the present study were expressed at high 
levels and influenced by DEC1 deficiency in BAT, whereas the same genes were expressed 
at low levels and not necessarily affected by DEC1 deficiency in the liver. These differences 
may be partly due to the minor contribution of PPARg to the regulation of lipid metabolism 
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in the liver. In fact, the expression of Pparg was substantially lower in the liver than in BAT. 
In addition, DEC2 may compensate for the loss of DEC1, because Dec2 expression was 
markedly upregulated in the Dec1-/- liver. These findings may explain why we observed no 
significant differences in the transcript levels of hepatic genes for lipid metabolism upon 
DEC1 deficiency. Although most hepatic genes examined in the present study are PPARg 
target genes, there may be additional regulatory factors controlling these genes, which need 
to be elucidated in future studies. 
 Various physiological functions, including body temperature, exhibit circadian rhythms 
that are, directly or indirectly, under the control of the master circadian factor, the 
CLOCK:BMAL1 heterodimer (Mohawk et al. 2012). CLOCK:BMAL1 activates clock genes 
through binding to E-boxes, while DEC1 participates in the circadian regulation by 
competing with CLOCK:BMAL1 for binding to the same E-boxes (Honma et al. 2002; 
Kawamoto et al. 2004). Ohishi et al. (2006) reported that the disruption of CLOCK function 
attenuated high-fat-diet-induced obesity. On the other hand, DEC1 deficiency led to similar 
results in this study to those reported. In addition, we found that body temperature increased 
in Dec1/ mice at ZT2, but not at ZT14, when compared with WT mice, resulting in the 
disruption of the day-night difference. Moreover, all of the PPARg target genes examined in 
this study were upregulated in Dec1/ BAT, at least at ZT14. Although the expression of 
Dec1, as well as Dec2, exhibited a day-night difference, the expression of most genes 
governed by PPARg did not (shown in Figure 3), suggesting that these genes are not direct 
targets of CLOCK:BMAL1. Therefore, DEC1 may influence circadian rhythms in lipid 
metabolism-related activities such as thermogenesis through interaction with PPARg:RXRa, 
but not through the interaction with CLOCK:BMAL1, suggesting another mechanism 
underlying the circadian regulation of PPARg-target genes. In fact, DEC1 deficiency almost 
disrupted the circadian rhythm of core temperature and prevented high-fat-diet-induced 
obesity, possibly due to the upregulation of Ucp1 in ZT2. Further studies are needed to 
uncover the finer details of the physiological role of DEC1 in lipid metabolism and 
thermogenesis. 
 In the present study, we obtained some inconsistent results, reason for which is difficult 
to explain. First, core temperature in Dec1/ mice was significantly increased in ZT2 but not 
in ZT14 compared with the WT mice although Ucp1 expression was upregulated in both ZT2 
and ZT14. The time lag between circadian phases of rhythms of Ucp1 expression and core 
temperature may explain the observed difference. Several factors other than UCP1 involved 
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in thermogenesis may also explain this discrepancy. Second, the fat volume of the abdominal 
region was significantly smaller in Dec1/ mice than in WT mice fed a control or high-fat 
diet. However, we found no difference in body weight between WT and Dec1/ mice fed a 
control diet from 5 to 16 weeks although there was a significant decrease in body weight of 
Dec1
/ mice at 4 weeks. Apparently, there are unknown mechanisms compensating these 
differences through uncharacterized pathways. The increased core temperature and the 
decreased body weight and fat volume observed in Dec1/ mice could be influenced by 
increased locomotor activity. However, the observed locomotor activities were not 
significantly different between WT and Dec1/ mice fed a control diet (unpublished data) 
although the activities of mice fed a high-fat diet were not examined. Future research should 
focus on phenotypes other than lipid metabolism under both high-fat and control diet 
conditions. 
 In nature, animals often face starvation; obese animals in the natural environment are 
uncommon. In this context, DEC1 appears to serve as a “energy-saving” factor to survive 
starvation. However, in the modern human lifestyle, energy-saving factors such as DEC1 
may promote obesity under excess nutrition conditions. In addition, DEC1 can be induced by 
environmental stimuli such as light and feeding (Honma et al. 2002; Kawamoto et al. 2006; 
Kato et al. 2014), and this elevated DEC1 expression may further promote obesity. We 
anticipate that our findings may provide new therapeutic and prophylactic avenues for the 
prevention and mitigation of obesity-related diseases.  
 
4 EXPERIMENTAL PROCEDUERS  
4.1 Animals.  
Male C57BL/6J WT and Dec1/ mice (Nakashima et al. 2008) were housed under a 12-h 
light/dark cycle at a constant temperature and given food and water ad libitum. All 
manipulations during the dark phase were performed using night vision goggles (Bushnell 
Corp.) or under a red dim light to avoid disruptions of circadian rhythms. All procedures 
were performed in compliance with standard principles and guidelines for the care and use of 
laboratory animals at Hiroshima University Institute of Biomedical and Health Sciences 
under the ethical permission of Animal Research Committee of Hiroshima University. 
 For the high-fat diet experiment, 4-week-old male WT and Dec1/ mice were divided 
into two groups that were fed either a high-fat diet (82% kcal fat, 15% kcal protein, and 3% 
kcal carbohydrate; F2HFHSD; Oriental Yeast Co. Ltd) or a control diet (40.6% kcal fat, 
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17.6% kcal protein, and 41.8% kcal carbohydrate; AIN93G). Mice were differentiated by ear 
punches. Weight and core temperature were measured weekly and core temperature was 
monitored using a BAT-12 Microprobe Thermometer equipped with a rectal probe for mice 
(Muromachi Kikai Co., Ltd). After 10–13 weeks, mice were scanned by micro-CT or 
sacrificed and subjected to histological analysis and RNA extraction.  
 
4.2 Isolation of RNA and quantitative real-time RT-PCR analysis.  
At 13 weeks after the initiation of the feeding experiment, 4-5 mice from each group were 
decapitated at the indicated time points in a normal light/dark cycle. All RNA preparations 
were obtained separately from visceral WAT, interscapular BAT, and liver of individual mice, 
and used to measure the transcript levels of various genes, as described previously (Ozaki et 
al. 2012). 
 Quantitative real-time RT-PCR analysis was performed using the ABI PRISM 7900 
Sequence Detection System (Applied Biosystems) as described (Gibson et al. 1996). First 
strand cDNA synthesis, and the sequences of the primers and TaqMan™ fluorogenic probes 
(Applied Biosystems) for mouse Dec1 and Dec2 have been described previously (Noshiro et 
al. 2005). The sequences of the primers and TaqMan™ fluorogenic probes for the other 
genes were designed using the ProbeFinder™ software of the Roche Universal Probe Library 
system (Roche Applied Science). The sequences and probe IDs are listed in Table 1.  
 
4.3 Micro-CT scan analysis of mouse fat.  
At 10 weeks after the initiation of the feeding experiment, mice were anesthetized by an 
intraperitoneal injection of pentobarbital (50 mg/kg body weight) and positioned with both 
legs fully extended. The body of each mouse was scanned at 36 µm with a SkyScan 1176-HT 
(SkyScan Co.). 2D image slices of the abdominal region (between the proximal end of the 
first lumbar vertebra and the distal end of the sixth lumbar vertebra) were reconstructed into a 
3D tomography image as shown in Figure 1b. The reconstituted visceral and subcutaneous fat 
depots were visualized and quantified by CT-Vol and CT-An software (SkyScan Co.). 
 
4.4 Histological analysis.  
Formalin-fixed visceral WAT, interscapular BAT, and liver were imbedded in paraffin, and 
4-µm thick sections were stained with hematoxylin and eosin using 17-week-old mice. 
Sections were analyzed at ×100 magnification using an Eclipse 80i microscope (Nikon Corp.), 
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and digital images (1,280 × 960 pixels) were obtained using NIS Elements D image analysis 
software (Nikon Corp.). The adipocytes’ sizes were determined with Lumina Vision 2.20 
(Mitani Inc.), measuring at least 1000 cells from each group of 8–10 mice. Oil droplet areas 
in BAT and liver were also measured with the same software. 
 
4.5 Luciferase reporter assay.  
Double-stranded DNA fragments containing three repeats of the PPRE consensus sequence 
(AGGTCAAAGGTCA) (Ijpenberg et al. 1997) were prepared by annealing the 
oligonucleotide pair of the consensus PPRE shown below. The fragments were used to 
construct a reporter plasmid using pGL4 with a minimal promoter (Promega). The 
construction of the expression plasmid (pcDNA3.1) for mouse DEC1 has been described 
previously (Noshiro et al. 2004). The expression plasmids (pCMX) for mouse PPARg and 
human RXRa were kindly supplied by Dr. M. Makishima (Nihon University, Japan). The 
oligonucleotides used for the consensus PPRE × 3 were upper strand: 5′-
CTAGCAGGGGACCAGGACAAAGGTCACGTTCGGGAGTCGACAGGGGACCAGGA
CAAAGGTCACGTTCGGGAGTCGACAGGGGACCAGGACAAAGGTCACGTTCGGGA
-3′, and lower strand: 5′-
TCGATCCCGAACGTGACCTTTGTCCTGGTCCCCTGCGACTCCCGAACGTGACCTTT
GTCCTGGTCCCCTGTCGACTCCCGAACGTGACCTTTGTCCTGGTCCCCTG-3′. 
 Mouse 3T3-L1 cells were inoculated at 1 × 104 cells/well in 96-well plastic plates and 
cultured in Dulbecco’s modified Eagle’s medium (Sigma-Aldrich) containing 1 mg/ml D-
glucose, 10% (v/v) fetal bovine serum (FBS) (HyClone), 50 µg/ml ascorbic acid, 32 U/ml 
penicillin and 40 µg/ml streptomycin at 37°C in a 5% CO2 incubator. For adipogenic 
differentiation of 3T3-L1 preadipocytes, the medium was changed to adipogenic induction 
medium containing 5% FBS, 1 µM dexamethasone (Sigma-Aldrich), 500 µM 3-isobutyl-1-
methylxanthine (Wako), 200 µM indomethacin (Wako), 5 µM troglitazone (Wako), and 10 
µg/ml insulin (Wako) (Pittenger et al. 1999). The medium was replaced with adipogenesis 
maintenance medium containing 10% FBS and 10 µg/ml insulin every 2 days after 
adipogenic induction. 3T3-L1 adipocytes were used for reporter assays 6 days after induction. 
DNA transfection of the luciferase constructs with the internal control plasmid pRL-TK and 
the expression plasmids was performed using Lipofectamine-LTX transfection reagent (Life 
Technologies). The ligands troglitazone (1 µM) and 9-cis retinoic acid (0.1 µM) for PPARg 
and RXRa, respectively, dissolved in dimethyl sulfoxide, were added to the culture medium 
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(Gottlicher et al. 1992; Willy et al. 1995). Two days after transfection, the cells were 
harvested and the cell lysate was analyzed using dual luciferase assay reagents (Promega). 
Three wells were measured for each assay, and luciferase activities were normalized against 
internal control values. Two independent transfection experiments were performed. 
 
4.6 ChIP assay.  
ChIP assays of PPRE using anti-DEC1 antibodies (Nakashima et al. 2008) were performed 
using a ChIP Assay Kit (Upstate) according to the manufacturer’s instructions. 
Differentiating 3T3-L1 adipocytes were used 6 days after induction. Cellular genomic DNA 
was cross-linked with formaldehyde and sonicated. DNA fragments were precipitated using 
anti-DEC1 antibodies (aDEC1) or control IgG (Co IgG). DNA samples recovered from 3T3-
L1 adipocytes were subjected to PCR using the gene specific primers listed below, to detect 
DEC1 binding to the PPRE region of Pparg, Lpl, and Plin1 (Schoonjans et al. 1996; Nagai et 
al. 2004). The PCR primers used were as follows: Pparg, 5′-
GTTAGCAGTTTGGCACAGCTAGGT-3′ and 5′-AAAATTGGAGCCCTCCCTGAGA-3′; 





4.7 Immunoprecipitation assay.  
HEK293 cells were cultured in Dulbecco’s modified Eagle’s medium containing 5% FBS, 
100 U/ml penicillin, and 100 µg/ml streptomycin at 37°C in a humidified atmosphere 
containing 5% CO2. HEK293 cells in a 10-cm dish were transfected with various 
combinations of pFLAG-DEC1, pFLAG-CMV2, pCMX-RXRa, and pCMX-PPARg using 
Lipofectamine 2000 (Invitrogen). Twenty-four hours after transfection, cells were harvested 
with lysis buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 5 mM EDTA, 1% NP-40) 
containing complete protease inhibitor cocktail (Roche). The lysates were mixed with anti-
FLAG Sepharose 4B beads (Sigma-Aldrich) in the presence of a ligand (5 µM troglitazone) 
and rotated for 2 h at 4°C. The beads were washed three times with cold lysis buffer. The 
bound proteins were eluted by boiling in SDS sample buffer and were analyzed by 
immunoblotting with anti-DEC1 (Nakashima et al. 2008), anti-PPARg (Cell Signaling 
Technologies, #2443) or anti-RXRa antibodies (Cell Signaling Technologies, #5388). The 
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immunoreactive proteins were visualized using IRDye® Secondary Antibody and the 
Odyssey® Infrared Imaging System (Li-Cor Biosciences). 
 
4.8 Statistical analysis. 
Results were expressed as mean ± SEM. We assessed the results by the Student’s t-test for 
comparing two groups, or by two-way ANOVA for multiple comparisons. A P value less 
than 0.05 was considered significant.  
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FIGURE 1 DEC1 deficiency attenuates obesity and fat mass. (a) Effects of DEC1 deficiency 
on body weight. Four-week-old WT mice and Dec1/ mice were fed a control (Co) or high-
fat (HF) diet for the experimental period. The inserts show the results of the statistical 
analysis using the values of 16-week-old mice (n = 8–10; **p < 0.01; ns, not significant by 
Student’s t-test). (b) Representative images from micro-CT scanning of entire mouse bodies 
(upper image) and reconstituted 3D structures of fat depots (lower image) in the abdominal 
region of mice. The cross sections at lumbar (L) 5 are shown in the lower images to 
discriminate adipose tissue. (c) The total abdominal and fat volumes from L1 to L6 were 
quantified. Values are mean ± SEM (n = 4–6; *p < 0.05; **p < 0.01 by Student’s t-test). (d, f, 
h) Microscope images of hematoxylin and eosin-stained sections of visceral white adipose 
tissue (WAT) (d), interscapular brown adipose tissue (BAT) (f), and liver (h). Scale bars 
indicate 100 µm (WAT and liver images) and 50 µm (BAT images). (e) Histograms of cell 
lengths of adipocytes determined for visceral WAT (d). Values are % of total cell numbers 
calculated from WAT samples of 8-10 mice (**p < 0.01 by two-way ANOVA). (g, i) Oil 
droplet areas in BAT (g) and liver (i) were measured, respectively. Values are mean ± SEM 
(n = 8–10; *p < 0.05; **p < 0.01 by Student’s t-test). (j) Representative morphology of livers 
of HF diet mice. Statistical comparison of data between the two genotypes are shown in the 
figure by red symbols. 
 
FIGURE 2 Thermogenesis is accelerated in Dec1/ mice. (a) Core temperature of 14-week-
old mice was measured at ZT2 and ZT14 during the feeding experiment. Values are mean ± 
SEM (n = 8–10; **p < 0.01 by Student’s t-test). (b) Transcript levels of Ucp1 in interscapular 
BAT were determined by real-time RT-PCR at ZT2 and ZT14. Data are shown as mean ± 
SEM (n = 4–5; *p < 0.05; **p < 0.01 by Student’s t-test). Statistical comparisons of data 
between the two genotypes are depicted by red symbols. 
 
FIGURE 3 (a) Expression profiles of various lipolysis-related genes were analyzed by real-
time RT-PCR in BAT, WAT, and liver of WT and Dec1/ mice at ZT2 and ZT14. Values are 
mean ± SEM (n = 4–5; *p < 0.05; **p < 0.01 by Student’s t-test). (b) Expression profiles of 
Dec1 and Dec2 transcripts in BAT, WAT, and liver of WT and Dec1/ mice at ZT2 and 
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ZT14. Data are expressed as mean ± SEM (n = 4–5; *p < 0.05; **p < 0.01 by Student’s t-test). 
Statistical comparisons of data between the two genotypes are depicted by red symbols. 
 
FIGURE 4 DEC1 interacts with the PPARg:RXRa heterodimer at the PPAR response 
element (PPRE). (a) The pGL4 luciferase reporter plasmid (4 ng) carrying three repeats of the 
consensus PPRE sequence (AGGTCAAAGGTCA) was co-transfected along with the 
indicated expression plasmids (40 ng of PPARg and RXRa; 20, 40, or 60 ng of DEC1) into 
3T3-L1 adipocytes. The relative luciferase activities are expressed as mean ± SEM (n = 4; *p 
< 0.05; **p < 0.01; ns, not significant by Student’s t-test). Co, control vector only. (b) ChIP 
assay of PPARg target genes (Lpl, Plin1, and Pparg). The input and the immunoprecipitated 
DNA fragments recovered from 3T3-L1 adipocytes were amplified using primer sets for Lpl, 
Plin1, and Pparg. (c) Interaction of DEC1 with RXRa in cells. HEK293 cells were 
transfected with various combinations of pFLAG-DEC1, pFLAG-CMV2, pCMX-PPARg, 
and pCMX-RXRa. The protein complexes in HEK293 cell lysates were pulled down with 
anti-FLAG antibody-coupled Sepharose beads and analyzed by Western blotting (WB) with 
anti-DEC1 (aDEC1), anti-RXRa (aRXRa), and anti-PPARg (aPPARg) antibodies.  
 
FIGURE 5 Model explaining the effect of DEC1 deficiency. DEC1 regulates lipolysis-
related genes in BAT through PPRE by binding to the PPARg:RXRa heterodimer. The 
consumption of lipid for energy generation or thermogenesis occurs mostly in BAT, where 
lipolytic genes are regulated by PPARg. DEC1 deficiency could activate lipolytic processing 
(b-oxidation of fatty acids, lipid transport, and electron transport) and thermogenesis by 
UCP1 in BAT, thereby decreasing lipid accumulation in WAT.  
 
 
 





